VivoSeq
Dermatology

Burn

31

Pipeline Programs↗

7

Active Trials↗

18

Companies Involved↗

Burn is a moderately active landscape with 31 programs across 18 companies. The most active players are INSYS Therapeutics Inc, Neurim Pharmaceuticals Ltd., Merck & Co.. 22 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

53/100

Pipeline Velocity

22/100

Mech. Concentration

9/100

Completion Rate

38/100

Attrition Rate

28/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

I

INSYS Therapeutics Inc

1 program

Phase 1N

Neurim Pharmaceuticals Ltd.

1 program

Phase 2Merck & Co. logo

Merck & Co.

1 program

Phase 3K

Kenvue Brands

2 programs

ApprovedA

Amring

1 program

ApprovedJ

Jagotec

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

18

clinical trials

Not yet recruiting4 · 22%
Terminated3 · 17%
Unknown status3 · 17%
Completed3 · 17%
Recruiting3 · 17%
Withdrawn2 · 11%

Clinical Trials

Trial Activity

18 trials

A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries
Recruiting·UUniversity of Manitoba·Phase 1/2·NCT05000983·25 enrolled
A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries
Recruiting·UUniversity of Manitoba·Phase 1/2·NCT04893863·20 enrolled
Early Maladaptive Patterns as Markers of Vulnerability and Targets for Therapeutic Intervention in Burned-out Healthcare Professionals
Recruiting·GGCS Ramsay Santé pour l'Enseignement et la Recherche·N/A·NCT06104202·208 enrolled
Reduction of Muscle Catabolism Through Brain Activation in Burn Patients
Not yet recruiting·—·N/A·NCT07435402·30 enrolled
Adaptive Support Ventilation and Targeted Fluid Resuscitation in Patients With Severe Burn Injury: A Prospective Cohort Study
Not yet recruiting·UUkrainian Society of Regional Anesthesia and Pain Therapy·N/A·NCT07689097·100 enrolled
Comparing the Safety and Efficacy of CO2 Laser-Assisted Triamcinolone Delivery With and Without 5-Fluorouracil for Hypertrophic Burn Scars: A Triple-Blinded, Randomized Split Scar Clinical Trial
Not yet recruiting·UUniversity of California, Davis·Preclinical·NCT07660120·65 enrolled
Adaptive Support Ventilation Versus Conventional Lung-Protective Ventilation in Severe Burn Injury Including Thermobaric and Drone-Related Burns: The BURN-ASV Randomized Controlled Trial
Not yet recruiting·UUkrainian Society of Regional Anesthesia and Pain Therapy·Preclinical·NCT07674563·100 enrolled
Glucose Control in Severely Burned Patients
Completed·SSunnybrook Health Sciences Centre·N/A·NCT01307306·45 enrolled
Vitamin E Supplementation in Burned Patients
Completed·TThe University of Texas Medical Branch, Galveston·Phase 2/3·NCT01749371·31 enrolled
Post Burn Cubital Tunnel Syndrome Response to High Intensity Laser Therapy Versus Shock Wave Therapy
Completed·AAhram Canadian University·Preclinical·NCT07102992·75 enrolled
Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population
Terminated·AAssistance Publique Hopitaux De Marseille·Phase 4·NCT02872272·7 enrolled
Superficial Partial-Thickness Burn Study
Terminated·—·Phase 4·NCT04601532·26 enrolled
Use of Progenitor Biological Bandages in Burn Care (Bru_PBB)
Terminated·DDr Anthony De Buys Roessingh·Phase 1/2·NCT05339490·76 enrolled
The Effect of High Dose Vitamin C in Burn Patients
Withdrawn·UUnited States Army Institute of Surgical Research·N/A·NCT00350077
Vitamin E Supplementation in Burn Patients
Withdrawn·SShriners Hospitals for Children·Phase 1·NCT01413620
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)